Richard Baldry

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Cerebrospinal Fluid

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Anne-Kristina Mercier, Abigail K Kois, Deeyen Karsanji, Richard Baldry, Filip Birve, Maria Hedwall, Oleksandr Molodetskyi, Michael Gillen
Zibotentan Can Be Co-administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug-Drug Interaction Study. Clinical pharmacology and therapeutics 116 (2) (2024)
Anne-Kristina Mercier, Abigail K Kois, Deeyen Karsanji, Richard Baldry, Filip Birve, Maria Hedwall, Oleksandr Molodetskyi, Michael Gillen
Zibotentan Can Be Co-administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug-Drug Interaction Study. Clinical pharmacology and therapeutics (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)